EDGAR Filing Documents for 0001193125-20-234651

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001193125-20-234651

Filing Date

2020-08-28

Accepted

2020-08-28 16:02:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	d54708df3.htm	F-3	749156
2	EX-4.1	d54708dex41.htm	EX-4.1	89547
3	EX-4.6	d54708dex46.htm	EX-4.6	296192
4	EX-4.7	d54708dex47.htm	EX-4.7	331607
5	EX-5.1	d54708dex51.htm	EX-5.1	13389
6	EX-5.2	d54708dex52.htm	EX-5.2	37786
7	EX-16.1	d54708dex161.htm	EX-16.1	2087
8	EX-23.1	d54708dex231.htm	EX-23.1	2099
9	GRAPHIC	g54708g0827233837125.jpg	GRAPHIC	2142
10	GRAPHIC	g54708g13g36.jpg	GRAPHIC	18660
11	GRAPHIC	g54708g23p08.jpg	GRAPHIC	41413
12	GRAPHIC	g54708g87l80.jpg	GRAPHIC	6736
13	GRAPHIC	g54708goodwinlogo.jpg	GRAPHIC	6086
	Complete submission text file	0001193125-20-234651.txt		1627111

Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435

Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100

Celyad Oncology SA (Filer) CIK: 0001637890 (see all company filings)